COMP is associated with different diseases and it is a well-known biomarker for pathologies that elicit cartilage destruction such as osteoarthritis, rheumatoid arthritis, intervertebral disc degeneration, and psoriatic arthritis [42]. This evidence concerns the gene COMP and rheumatoid arthritis.